Effects of two combined monophasic and triphasic ethinylestradiol/ gestodene oral contraceptives on natural inhibitors and other hemostatic variables

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3135184 9 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Effects of two combined monophasic and triphasic ethinylestradiol/ gestodene oral contraceptives on natural inhibitors and other hemostatic variables
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Objective: To evaluate the effects of two preparations of combined oral contraceptives (COCs), the monophasic COC containing 30 μg ethinylestradiol and 75 μg gestodene and the triphasic COC containing 30/40/30 ethinylestradiol and 50/70/100 μg gestodene on seven natural inhibitors and hemostatic variables. Method: Forty-four healthy young women, randomly allocated into two groups (A and B) received the two preparations of COCs, respectively. The following variables were tested in a basic examination and at 1-, 3- and 6-month intervals to evaluate the role of the above preparations on the hemostatic balance of prothrombin time, fibrinogen, antithrombin III activity, protein C activity, total protein S antigen, plasminogen activity and lupus anticoagulant. Results: Group A women presented shorter prothrombin time at 6 months, an increased fibrinogen level at 3 months, no influence on the anticoagulant factors, antithrombin III, protein C and total protein S and an increased plasminogen activity at the 1st and 3rd months of treatment. On the other hand, group B women presented shorter prothrombin time at 3 months, no increase in fibrinogen, a decrease in antithrombin III activity and total protein S activity at the 6th month, whereas protein C and plasminogen activities were found to be increased at the 3rd and 1st, 3rd and 6th month, respectively. Conclusions: The study did not find differences between the two treatment groups, for the evaluated parameters. This finding is clearly important in the light of the recent epidemiological reports on third-generation COCs. However, differences were found among the various periods of administration of both COCs.
Έτος δημοσίευσης:
1997
Συγγραφείς:
Creatsas, G.
Kontopoulou-Griva, I.
Deligeoroglou, E.
Digenopoulou, L.
Tsangaris, A.
Kallipolitis, G.
Milingos, S.
Michalas, S.
Περιοδικό:
The European Journal of Contraception and Reproductive Health Care
Εκδότης:
LIBRAPHARM/INFORMA HEALTHCARE
Τόμος:
2
Αριθμός / τεύχος:
1
Σελίδες:
31-38
Λέξεις-κλειδιά:
antithrombin III; estradiol derivative; ethinylestradiol; fibrinogen; gestodene; lupus anticoagulant; oral contraceptive agent; plasminogen; pregnane derivative; progesterone derivative; protein C, adolescent; adult; article; blood; clinical trial; comparative study; drug effect; female; hemostasis; human; prothrombin time; randomized controlled trial; time, Adolescent; Adult; Antithrombin III; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Fibrinogen; Hemostasis; Humans; Lupus Coagulation Inhibitor; Norpregnenes; Plasminogen; Progesterone Congeners; Protein C; Prothrombin Time; Time Factors
Επίσημο URL (Εκδότης):
DOI:
10.1080/13625189709049932
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.